| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |